China, Aug. 13 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Mechanistic Study of H3K18 Lactylation-Mediated EGR1/TGF-β Signaling Axis in Airway Fibrosis of COPD'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130005
Registration Time: 2026/08/12
Type: Observational study
Primary Sponsor: The First People’s Hospital of Jingzhou
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=335855
Published by HT Digital Content Services with permission from Health Daily Digest....